Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 11/20 | 0.52 |
| ▸ | CA12 | O43570 | 10/20 | 0.52 |
| ▸ | CA9 | Q16790 | 10/20 | 0.52 |
| ▸ | CA1 | P00915 | 7/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 1/20 | 0.38 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP7 | P09237 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8779885 | 0.90 | CA2 (0.41) | CA2CA12CA9CA1CA14 | |
| SCHEMBL7605554 | 0.79 | CA2 (0.59) | CA2CA12CA9CA1CA14 | |
| SCHEMBL4315677 | 0.77 | ALDH1A1 (0.62) | CA2CA12CA9CA1CA14 | |
| SCHEMBL31086968 | 0.77 | TSHR (0.62) | CA2CA12CA9CA1CA14 | |
| SCHEMBL9573621 | 0.77 | MMP2 (0.50) | CA2CA1PKMALDH1A1MMP2 | |
| SCHEMBL1153998 | 0.77 | GAA (0.62) | CA2CA12CA9CA1SMN1; SMN2 | |
| SCHEMBL296383 | 0.75 | HTR6 (0.58) | CA2CA12CA9CA1CA14 | |
| SCHEMBL8779813 | 0.75 | STS (0.41) | CA2CA12CA1LMNAKDM4E | |
| SCHEMBL21114887 | 0.75 | HTR2A (0.39) | CA2CA12CA9CA1CA14 | |
| SCHEMBL8996770 | 0.73 | TSHR (0.42) | CA2CA12CA9CA1CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10869884-B2 | Cyclodextrin based polymers, methods, compositions and applications thereof | ATEN PORUS LIFESCIENCES (IN) | 2020-12-22 | — | — | US | disclosed |
| EP-3515501-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | Aten Porus Lifesciences (IN) | 2019-07-31 | — | — | EP | disclosed |
| US-20190209605-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | ATEN PORUS LIFESCIENCES (IN) | 2019-07-11 | — | — | US | disclosed |
| WO-2018051298-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | ATEN PORUS LIFESCIENCES (IN) | 2018-03-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10869884-B2 | Cyclodextrin based polymers, methods, compositions and applications thereof | NPC1L1, CETP, LIPA | CA2 1967/4885CA12 1288/4885CA9 874/4885 |
| US-20190209605-A1 | CYCLODEXTRIN BASED POLYMERS, METHODS, COMPOSITIONS AND APPLICATIONS THEREOF | NPC1L1, CETP, LIPA | CA2 1967/4885CA12 1288/4885CA9 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.